Medications

US approves highly anticipated Eli Lilly weight loss drug

The US Food and Drug Administration (FDA) on Wednesday announced it had approved Eli Lilly's highly anticipated weight loss drug Zepbound, the latest entrant in a field of powerful—and lucrative—new obesity medicines.

Inflammatory disorders

New sensor objectively measures scratching intensity

Akhil Padmanabha knows about itching. His chronic itching caused by severe eczema was so debilitating that he was hospitalized twice and had to be home-schooled during most of his high school years. Itch so impacted his life ...

page 1 from 19